Salem Investment Counselors’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.7K | Hold |
621
| – | – | ﹤0.01% | 865 |
|
|
2026
Q1 | $13.7K | Buy |
+621
| New | +$10.8K | ﹤0.01% | 822 |
|
|
2025
Q4 | – | Sell |
-621
| Closed | -$9.84K | – | 506 |
|
|
2025
Q3 | $9.84K | Hold |
621
| – | – | ﹤0.01% | 885 |
|
|
2025
Q2 | $7.11K | Hold |
621
| – | – | ﹤0.01% | 900 |
|
|
2025
Q1 | $8.4K | Hold |
621
| – | – | ﹤0.01% | 862 |
|
|
2024
Q4 | $10.5K | Hold |
621
| – | – | ﹤0.01% | 827 |
|
|
2024
Q3 | $12.6K | Hold |
621
| – | – | ﹤0.01% | 813 |
|
|
2024
Q2 | $14K | Hold |
621
| – | – | ﹤0.01% | 793 |
|
|
2024
Q1 | $16.3K | Hold |
621
| – | – | ﹤0.01% | 752 |
|
|
2023
Q4 | $19.6K | Sell |
621
-200
| -24% | -$5.43K | ﹤0.01% | 700 |
|
|
2023
Q3 | $23K | Sell |
821
-53
| -6% | -$1.82K | ﹤0.01% | 654 |
|
|
2023
Q2 | $32.2K | Sell |
874
-60
| -6% | -$1.83K | ﹤0.01% | 608 |
|
|
2023
Q1 | $28K | Hold |
934
| – | – | ﹤0.01% | 637 |
|
|
2022
Q4 | $28.6K | Hold |
934
| – | – | ﹤0.01% | 607 |
|
|
2022
Q3 | $23K | Hold |
934
| – | – | ﹤0.01% | 612 |
|
|
2022
Q2 | $30K | Hold |
934
| – | – | ﹤0.01% | 593 |
|
|
2022
Q1 | $29K | Sell |
934
-567
| -38% | -$17.7K | ﹤0.01% | 597 |
|
|
2021
Q4 | $50K | Buy |
1,501
+620
| +70% | +$19.3K | ﹤0.01% | 558 |
|
|
2021
Q3 | $26K | Hold |
881
| – | – | ﹤0.01% | 598 |
|
|
2021
Q2 | $31K | Hold |
881
| – | – | ﹤0.01% | 550 |
|
|
2021
Q1 | $25K | Hold |
881
| – | – | ﹤0.01% | 560 |
|
|
2020
Q4 | $22K | Hold |
881
| – | – | ﹤0.01% | 556 |
|
|
2020
Q3 | $18K | Hold |
881
| – | – | ﹤0.01% | 506 |
|
|
2020
Q2 | $14K | Hold |
881
| – | – | ﹤0.01% | 531 |
|
|
2020
Q1 | $8K | Hold |
881
| – | – | ﹤0.01% | 536 |
|
|
2019
Q4 | $16K | Hold |
881
| – | – | ﹤0.01% | 514 |
|
|
2019
Q3 | $13K | Hold |
881
| – | – | ﹤0.01% | 508 |
|
|
2019
Q2 | $21K | Sell |
881
-61
| -6% | -$1.8K | ﹤0.01% | 475 |
|
|
2019
Q1 | $37K | Buy |
+942
| New | +$34.3K | ﹤0.01% | 312 |
|
|
2018
Q4 | – | Sell |
-942
| Closed | -$37K | – | 210 |
|
|
2018
Q3 | $37K | Hold |
942
| – | – | ﹤0.01% | 312 |
|
|
2018
Q2 | $42K | Hold |
942
| – | – | ﹤0.01% | 306 |
|
|
2018
Q1 | $44K | Hold |
942
| – | – | 0.01% | 297 |
|
|
2017
Q4 | $47K | Hold |
942
| – | – | 0.01% | 318 |
|
|
2017
Q3 | $49K | Sell |
942
-1
| -0.1% | -$47 | 0.01% | 308 |
|
|
2017
Q2 | $36K | Buy |
943
+1
| +0.1% | +$39 | ﹤0.01% | 348 |
|
|
2017
Q1 | $35K | Hold |
942
| – | – | ﹤0.01% | 415 |
|
|
2016
Q4 | $21K | Buy |
+942
| New | +$19.3K | ﹤0.01% | 434 |
|
Other funds holding CC
CCPM
Salem Investment Counselors's CC Position: Q2 2026 in Review
Salem Investment Counselors held its Chemours (CC) position steady in Q2 2026 at 621 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #865.
Salem Investment Counselors first reported a position in CC in Q4 2016 and has held it in 37 quarters since. The position peaked at $50K in Q4 2021. 474 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- Salem Investment Counselors held 621 shares of Chemours worth $12.7K as of Q2 2026.
- Salem Investment Counselors left its Chemours share count unchanged in Q2 2026.
- Chemours made up ﹤0.01% of Salem Investment Counselors's portfolio in Q2 2026, its #865 holding.
- Salem Investment Counselors first reported a position in Chemours in Q4 2016 and has held it in 37 quarters since.
- Salem Investment Counselors's Chemours position peaked at $50K in Q4 2021.
- 474 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.